MovDisordV3, Pmc, Checkpoint, bibRecord, 000338

Impact of belief in neuroprotection on therapeutic intervention in Parkinson disease

Identifieur interne : 000338 ( Pmc/Checkpoint ); précédent : 000337; suivant : 000339

Impact of belief in neuroprotection on therapeutic intervention in Parkinson disease

Auteurs : Rodger J. Elble ; Oksana Suchowersky [Canada] ; Stephanie Shaftman ; William J. Weiner ; Peng Huang ; Barbara Tilley

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2010.

RBID : PMC:2891220

Abstract

We explored the hypotheses that an investigator’s belief in a putative neuroprotective agent might influence the timing of symptomatic intervention and the assessment of signs and symptoms of Parkinson patients with the Unified Parkinson Disease Rating Scale (UPDRS). These hypotheses were tested with Cox and general linear modeling, using data from a previously published double-blind placebo-controlled futility trial of coenzyme Q₁₀ and GPI-1485. We found the investigators’ level of confidence in these agents had no effect on the time to symptomatic therapy or on the change in UPDRS during 12 months of treatment.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891220

DOI: 10.1002/mds.22997
PubMed: 20131372
PubMed Central: 2891220

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Pmc, to step Corpus: 000082
to stream Pmc, to step Curation: 000082

Links to Exploration step

PMC:2891220

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of belief in neuroprotection on therapeutic intervention in Parkinson disease</title>
<author><name sortKey="Elble, Rodger J" sort="Elble, Rodger J" uniqKey="Elble R" first="Rodger J." last="Elble">Rodger J. Elble</name>
<affiliation><nlm:aff id="A1"> Department of Neurology, Southern Illinois University School of Medicine</nlm:aff>
<wicri:noCountry code="subfield">Southern Illinois University School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Suchowersky, Oksana" sort="Suchowersky, Oksana" uniqKey="Suchowersky O" first="Oksana" last="Suchowersky">Oksana Suchowersky</name>
<affiliation wicri:level="4"><nlm:aff id="A2"> Departments of Medical Genetics and Clinical Neurosciences, University of Calgary</nlm:aff>
<country>Canada</country>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
<orgName type="university">Université de Calgary</orgName>
</affiliation>
</author>
<author><name sortKey="Shaftman, Stephanie" sort="Shaftman, Stephanie" uniqKey="Shaftman S" first="Stephanie" last="Shaftman">Stephanie Shaftman</name>
<affiliation><nlm:aff id="A3"> Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina</nlm:aff>
<wicri:noCountry code="subfield">Medical University of South Carolina</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Weiner, William J" sort="Weiner, William J" uniqKey="Weiner W" first="William J." last="Weiner">William J. Weiner</name>
<affiliation><nlm:aff id="A4"> Department of Neurology, University of Maryland School of Medicine</nlm:aff>
<wicri:noCountry code="subfield">University of Maryland School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Huang, Peng" sort="Huang, Peng" uniqKey="Huang P" first="Peng" last="Huang">Peng Huang</name>
<affiliation><nlm:aff id="A5"> Department of Oncology, Johns Hopkins University</nlm:aff>
<wicri:noCountry code="subfield">Johns Hopkins University</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Tilley, Barbara" sort="Tilley, Barbara" uniqKey="Tilley B" first="Barbara" last="Tilley">Barbara Tilley</name>
<affiliation><nlm:aff id="A6"> University of Texas Health Science Center School of Public Health at Houston</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">20131372</idno>
<idno type="pmc">2891220</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891220</idno>
<idno type="RBID">PMC:2891220</idno>
<idno type="doi">10.1002/mds.22997</idno>
<date when="2010">2010</date>
<idno type="wicri:Area/Pmc/Corpus">000082</idno>
<idno type="wicri:Area/Pmc/Curation">000082</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000338</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Impact of belief in neuroprotection on therapeutic intervention in Parkinson disease</title>
<author><name sortKey="Elble, Rodger J" sort="Elble, Rodger J" uniqKey="Elble R" first="Rodger J." last="Elble">Rodger J. Elble</name>
<affiliation><nlm:aff id="A1"> Department of Neurology, Southern Illinois University School of Medicine</nlm:aff>
<wicri:noCountry code="subfield">Southern Illinois University School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Suchowersky, Oksana" sort="Suchowersky, Oksana" uniqKey="Suchowersky O" first="Oksana" last="Suchowersky">Oksana Suchowersky</name>
<affiliation wicri:level="4"><nlm:aff id="A2"> Departments of Medical Genetics and Clinical Neurosciences, University of Calgary</nlm:aff>
<country>Canada</country>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
<orgName type="university">Université de Calgary</orgName>
</affiliation>
</author>
<author><name sortKey="Shaftman, Stephanie" sort="Shaftman, Stephanie" uniqKey="Shaftman S" first="Stephanie" last="Shaftman">Stephanie Shaftman</name>
<affiliation><nlm:aff id="A3"> Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina</nlm:aff>
<wicri:noCountry code="subfield">Medical University of South Carolina</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Weiner, William J" sort="Weiner, William J" uniqKey="Weiner W" first="William J." last="Weiner">William J. Weiner</name>
<affiliation><nlm:aff id="A4"> Department of Neurology, University of Maryland School of Medicine</nlm:aff>
<wicri:noCountry code="subfield">University of Maryland School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Huang, Peng" sort="Huang, Peng" uniqKey="Huang P" first="Peng" last="Huang">Peng Huang</name>
<affiliation><nlm:aff id="A5"> Department of Oncology, Johns Hopkins University</nlm:aff>
<wicri:noCountry code="subfield">Johns Hopkins University</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Tilley, Barbara" sort="Tilley, Barbara" uniqKey="Tilley B" first="Barbara" last="Tilley">Barbara Tilley</name>
<affiliation><nlm:aff id="A6"> University of Texas Health Science Center School of Public Health at Houston</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">We explored the hypotheses that an investigator’s belief in a putative neuroprotective agent might influence the timing of symptomatic intervention and the assessment of signs and symptoms of Parkinson patients with the Unified Parkinson Disease Rating Scale (UPDRS). These hypotheses were tested with Cox and general linear modeling, using data from a previously published double-blind placebo-controlled futility trial of coenzyme Q<sub>10</sub>
 and GPI-1485. We found the investigators’ level of confidence in these agents had no effect on the time to symptomatic therapy or on the change in UPDRS during 12 months of treatment.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article" xml:lang="EN"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
  <pmc-dir>properties manuscript</pmc-dir>
  <front><journal-meta><journal-id journal-id-type="nlm-journal-id">8610688</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5937</journal-id>
<journal-id journal-id-type="nlm-ta">Mov Disord</journal-id>
<journal-title>Movement disorders : official journal of the Movement Disorder Society</journal-title>
<issn pub-type="ppub">0885-3185</issn>
<issn pub-type="epub">1531-8257</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">20131372</article-id>
<article-id pub-id-type="pmc">2891220</article-id>
<article-id pub-id-type="doi">10.1002/mds.22997</article-id>
<article-id pub-id-type="manuscript">NIHMS165374</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Impact of belief in neuroprotection on therapeutic intervention in Parkinson disease</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Elble</surname>
<given-names>Rodger J.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref rid="A1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Suchowersky</surname>
<given-names>Oksana</given-names>
</name>
<degrees>MD</degrees>
<xref rid="A2" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Shaftman</surname>
<given-names>Stephanie</given-names>
</name>
<degrees>MSc, MS</degrees>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Weiner</surname>
<given-names>William J.</given-names>
</name>
<degrees>MD</degrees>
<xref rid="A4" ref-type="aff">4</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Huang</surname>
<given-names>Peng</given-names>
</name>
<degrees>PhD</degrees>
<xref rid="A5" ref-type="aff">5</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Tilley</surname>
<given-names>Barbara</given-names>
</name>
<degrees>PhD</degrees>
<xref rid="A6" ref-type="aff">6</xref>
</contrib>
<on-behalf-of>on behalf of the NINDS NET-PD investigators</on-behalf-of>
</contrib-group>
<aff id="A1"><label>1</label>
 Department of Neurology, Southern Illinois University School of Medicine</aff>
<aff id="A2"><label>2</label>
 Departments of Medical Genetics and Clinical Neurosciences, University of Calgary</aff>
<aff id="A3"><label>3</label>
 Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina</aff>
<aff id="A4"><label>4</label>
 Department of Neurology, University of Maryland School of Medicine</aff>
<aff id="A5"><label>5</label>
 Department of Oncology, Johns Hopkins University</aff>
<aff id="A6"><label>6</label>
 University of Texas Health Science Center School of Public Health at Houston</aff>
<author-notes><corresp id="FN1">Correspondence: Dr. Elble, Rodger J. Elble, MD, PhD, Department of Neurology, Southern Illinois University School of Medicine, PO Box 19643, Springfield, IL 62794-9643, 217-545-7182 (phone), 217-545-1903 (Fax), <email>relble@siumed.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>2</day>
<month>1</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="ppub"><day>15</day>
<month>6</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>15</day>
<month>6</month>
<year>2011</year>
</pub-date>
<volume>25</volume>
<issue>8</issue>
<fpage>1082</fpage>
<lpage>1086</lpage>
<abstract><p id="P1">We explored the hypotheses that an investigator’s belief in a putative neuroprotective agent might influence the timing of symptomatic intervention and the assessment of signs and symptoms of Parkinson patients with the Unified Parkinson Disease Rating Scale (UPDRS). These hypotheses were tested with Cox and general linear modeling, using data from a previously published double-blind placebo-controlled futility trial of coenzyme Q<sub>10</sub>
 and GPI-1485. We found the investigators’ level of confidence in these agents had no effect on the time to symptomatic therapy or on the change in UPDRS during 12 months of treatment.</p>
</abstract>
<kwd-group><kwd>Parkinson disease</kwd>
<kwd>bias</kwd>
<kwd>clinical trial</kwd>
<kwd>Unified Parkinson Disease Rating Scale</kwd>
</kwd-group>
<contract-num rid="NS1">U01 NS043127-08
				||NS</contract-num>
<contract-sponsor id="NS1">National Institute of Neurological Disorders and Stroke  : NINDS</contract-sponsor>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Alberta</li>
</region>
<settlement><li>Calgary</li>
</settlement>
<orgName><li>Université de Calgary</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Elble, Rodger J" sort="Elble, Rodger J" uniqKey="Elble R" first="Rodger J." last="Elble">Rodger J. Elble</name>
<name sortKey="Huang, Peng" sort="Huang, Peng" uniqKey="Huang P" first="Peng" last="Huang">Peng Huang</name>
<name sortKey="Shaftman, Stephanie" sort="Shaftman, Stephanie" uniqKey="Shaftman S" first="Stephanie" last="Shaftman">Stephanie Shaftman</name>
<name sortKey="Tilley, Barbara" sort="Tilley, Barbara" uniqKey="Tilley B" first="Barbara" last="Tilley">Barbara Tilley</name>
<name sortKey="Weiner, William J" sort="Weiner, William J" uniqKey="Weiner W" first="William J." last="Weiner">William J. Weiner</name>
</noCountry>
<country name="Canada"><region name="Alberta"><name sortKey="Suchowersky, Oksana" sort="Suchowersky, Oksana" uniqKey="Suchowersky O" first="Oksana" last="Suchowersky">Oksana Suchowersky</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Pmc/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000338 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000338 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    RBID
   |clé=     PMC:2891220
   |texte=   Impact of belief in neuroprotection on therapeutic intervention in Parkinson disease
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i   -Sk "pubmed:20131372" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Impact of belief in neuroprotection on therapeutic intervention in Parkinson disease

Impact of belief in neuroprotection on therapeutic intervention in Parkinson disease

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki